Determination of therapeutic oligonucleotides using capillary gel electrophoresis

Biomedical Chromatography

Volumn 26, Issue 4, 2012, Pages 409-418

  Chen, Buyun ^a   Bartlett, Michael G ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Bioanalysis; Capillary electrophoresis; Metabolite; Oligonucleotide

Indexed keywords

CAPILLARY ELECTROPHORESIS; CHEMICAL MODIFICATION; MASS SPECTROMETRY; METABOLITES;

BIOANALYSIS; CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRIES; CAPILLARY-GEL ELECTROPHORESIS; CLINICAL STUDY; HALF LIVES; IN-VIVO; MECHANISM OF ACTION; PRECLINICAL STUDIES; SIMULTANEOUS DETERMINATIONS; SINGLE BASIS;

OLIGONUCLEOTIDES;

2 O (2 METHOXYETHYL)OLIGONUCLEOTIDE; AGAROSE; ISIS 104838; ISIS 13650; ISIS 15839; ISIS 16952; OLIGONUCLEOTIDE; POLYACRYLAMIDE GEL; POVIDONE; UNCLASSIFIED DRUG;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; DRUG DETERMINATION; DRUG ISOLATION; DRUG METABOLISM; GEL; GEL ELECTROPHORESIS; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; SOLID PHASE EXTRACTION;

EID: 84858005735     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1696     Document Type: Article

References (65)

1. Agrawal S, Temsamani J and Tang JY. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proceedings of the National Academy of Science USA 1991; 88: 7595-7599.
2. Barry JP, Muth J, Law SJ, Karger BL and Vouros P. Analysis of modified oligonucleotides by capillary electrophoresis in a polyvinylpyrrolidone matrix coupled with electrospray mass spectrometry. Journal of Chromatography. A 1996; 732: 159-166.
3. Bellon L, Maloney L, Zinnen SP, Sandberg JA and Johnson KE. Quantitative determination of a chemically modified hammerhead ribozyme in blood plasma using 96-well solid-phase extraction coupled with high-performance liquid chromatography or capillary gel electrophoresis. Analytical Biochemistry 2000; 238 228-240.
4. Chen R, Luo X, Di X, Li Y, Sun Y and Hu Y. Single-based resolution for oligodeoxynucleotides and their phosphorothioate modifications by replaceable capillary gel electrophoresis. Journal of Chromatography B 2006; 843: 334-338.
5. Chen SH and Gallo JM. Use of capillary electrophoresis methods to characterize the pharmacokinetics of antisense drugs. Electrophoresis 1998; 19(16-17): 2861-2869.
6. Chen SH, Qian M, Brennan JM and Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. Journal of Chromatography B 1997; 692 43-51.
7. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. Journal of Pharmacology and Experimental Therapy 1993; 267: 1181-1190.
8. 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. Journal of Pharmacology and Experimental Therapy 1994; 269: 89-94.
9. Crooke ST. Therapeutic applications of oligonucleotides. Annual Review of Pharmacology and Toxicology 1992; 32: 329-376.
10. Crooke ST. Vitravene - another piece in the mosaic. Antisense & Nucleic Acid Drug Development 1998; 8: vii.
11. Crooke, ST. Antisense strategies. Current Molecular Medicine 2004; 4: 465-487.
12. Crooke ST, Grillone LR, Tendolkar A, Garrett A, Fratkin MJ, Leeds J and Barr WH. A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts. Clinical Pharmacological Therapy 1994; 56: 641-646.
13. Crooke ST, Graham MJ, Zuckerman JE, Brooks D, Conklin BS, Cummins LL, Greig MJ, Guinosso CJ, Kornburst D, Manoharan M, Sasmor HM, Schleich T, Tivel KL and Griffey RH. Pharmacokinetic properties of several novel oligonucleotide analogs in mice. Journal of Pharmacology and Experimental Therapy 1996; 277: 923-937.
14. DeClercq E, Eckstein F and Merigan TC. Interferon induction increased through chemical modification of a synthetic polyribonucleotide. Science 1969; 165: 1137-1139.
15. De Gennes PG. Reptation of a polymer chain in the presence of fixed obstacles. Journal of Chemical Physics 1971; 55: 572-579.
16. Gao Q and Yeung E. A matrix for DNA separation: genotyping and sequencing using poly (vinylpyrrolidone) solution in uncoated capillaries. Analytical Chemistry 1998; 70: 1382-1388.
17. Geary RS, Leeds JM, Fitchett J, Burckin T, Troung L, Spainhour C, Creek M, and Levin AA. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metabolism and Disposition 1997; 25: 1272-1281.
18. Geary RS, Matson J and Levin AA. A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue. Analytical Biochemistry 1999; 274: 241-248.
19. Geary RS, Khatsenko O, Bunker K, Crooke R, Moore M, Burckin T, Truong LA, Sasmor H and Levin AA. Absolute bioavailability of 2′-o-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats. Journal of Pharmacology and Experimental Therapy 2001a; 296: 898-904.
20. Geary RS, Watanabe TA, Truong L, Freier S, Lesnik EA, Sioufi NB, Sasmor H, Manoharan M and Levin AA. Pharmacokinetic properties of 2′-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. Journal of Pharmacology and Experimental Therapy 2001b; 296: 890-897.
21. Geary RS, Yu RZ, Watanabe T, Henry SP, Hardee GE, Chappell A, Matson J, Sasmor H, Cummins L and Levin AA. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2′-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. Drug Metabolism and Disposition 2003; 31: 1419-1428.
22. Gilar M, Belenky A, Smisek DL, Bourque A and Cohen AS. Kinetics of phosphorothioate oligonucleotide metabolism in biological fluids. Nucleic Acids Research 1997; 25: 3615-3620.
23. Gilar M, Belenky A, Budman Y, Smisek DL and Cohen AS. Study of phosphorothioate-modified oligonucleotide resistance to 3′-exonuclease using capillary electrophoresis. Journal of Chromatography B Biomedical Science Applications 1998; 714: 13-20.
24. Gilon N and Potin-Gautier M. Capillary electrophoresis applied to the determination of some seleno compounds. Journal of Chromatography. A 1996; 732: 369-376.
25. Graham MJ, Crooke ST, Lemonidis KM, Gaus HJ, Templin MV and Crooke RM. Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration. Biochemical Pharmacology 2001; 62: 297-306.
26. Griffin LC, Tidmarsh GF, Bock LC and Toole JJ, Leung LL. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 1993; 81: 3271-3276.
27. Guttman A. Gel and polymer-solution mediated separation of biopolymers by capillary electrophoresis. Journal of Chromatographic Siences 2003; 41: 449-459.
28. Guttman A and Schwartz HE. Artifacts related to sample introduction in capillary gel electrophoresis affecting separation performance and quantitation. Analytical Chemistry 1995; 67: 2279-2283.
29. Guttman A, Paulus A, Cohen AS, Karger BL, Rodriguez H and Hancock WS. Electrophoresis'88, Schafer-Neilsen C (ed.). VCH: Weinheim, 1988; 151-159.
30. Harsch A and Vouros P. Interfacing of CE in a PVP matrix to ion trap mass spectrometry: analysis of isomeric and structurally related (N-acetylamino)flourine-modified oligonucleotides. Analytical Chemistry 1998: 70; 3021-3027.
31. Heiger DN, Cohen AS and Karger BL. Separation of DNA restriction fragments by high performance capillary electrophoresis with low and zero crosslinked polyacrylamide using continuous and pulsed electric fields. Journal of Chromatography 1990; 516: 33-48.
32. Henry SP, Novotny W, Leeds J, Auletta C and Kornbrust D J. Inhibition of coagulation by a phosphorothioate oligonucleotide Antisense & Nucleic Acid Drug Development 1997a; 7: 503-510.
33. Henry SP, Monteith D and Levin AA. Antisense oligonucleotide inhibitors for the treatment of cancer. 2. Toxicologic properties of phosphorothioate oligodeoxynucleotides. Anti-Cancer Drug Design 1997b; 12: 395-408.
34. Hjerten S, Srichaiyo T and Palm A. UV-Transparent, replaceable agarose gels for molecular-sieve (capillary) electrophoresis of proteins and nucleic acids. Biomedical Chromatography 1994; 8: 73-76.
35. Iversen P. In vivo studies with phosphorothiotate oligonucleotides: pharmacokinetic prologue. Anticancer Drug Design 1991; 6: 531-538.
36. Krivácsy AZ, Gelencsér JH, Kiss G and Sárvári ZS. Electrokinetic injection in capillary electrophoresis and its application to the analysis of inorganic compounds. Journal of Chromatography. A 1999; 834: 21-44.
37. Lee SL. Non-clinical regulatory considerations of therapeutic oligonucleotide based agents. AAPS November 2008.
38. Lee YH and Lin TI. Determintation of metal cations by capillary electrophoresis effect of background carrier and complexing agents. Journal of Chromatography. A 1994; 675: 227-236.
39. Leeds JM, Graham MJ, Truong L and Cummins LL. Quantitation of phosphorothioate oligonucleotides in human plasma. Analytical Biochemistry 1996; 235: 36-43.
40. Maier M, Fritz H, Gerster M, Schewitz J and Bayer E. Quantitation of phosphorothioate oligonucleotides in human blood plasma using a nanoparticle-based method for solid-phase extraction. Analytical Chemistry 1998; 70(11): 2197-2204.
41. Nicklin PL, Ambler J, Mitchelson A, Bailey D, Phillips JA, Craig SJ and Monia BP. Preclinical profiling of modified oligonucleotides: anticoagulation and pharmacokinetic properties. Nucleosides & Nucleotides 1997; 16: 1145-1153.
42. Noll BO, McLuskie MJ, Sniatala T, Lohner A, Yuill S, Kreig AM, Schetter C, Davis HL and Uhlmann E. Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration. Biochemical Pharmacology 2005; 69: 981-991.
43. Noll BO, Debelak H and Uhlmann E. Identification and quantification of GC-rich oligodeoxynucleotides in tissue extracts by capillary gel electrophoresis. Journal of Chromatography B 2007; 847: 153-161.
44. Nyce JW. Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases. Expert Opinion on Investigation of Drugs 1997; 6: 1149-1156.
45. Paril SD, Rohdes DG and Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. The AAPS Journal 2005; 7: 1.
46. Qiugley WWC and Dovichi NJ. Capillary electrophoresis for the analysis of biopolymers. Analytical Chemistry 2004; 76: 4645-4658.
47. Reyderman L and Stavchansky S. Determination of single-stranded oligodeoxynucleotides by capillary gel electrophoresis with laser induced fluorescence and on column derivatization. Journal of Chromatography. A 1996; 755: 271-280.
48. Reyderman L and Stavchansky S. Quantitative determination of short single-stranded oligonucleotides from blood plasma using capillary electrophoresis with laser-induced fluorescence. Analytical Chemistry 1997; 69: 3218-3222.
49. Righetti PG, Gelfi C and Acunto MR. Recent progress in DNA analysis by capillary electrophoresis. Electrophoresis 2002; 23: 1361-1374.
50. Saxena SK and Ackerman EJ. Microinjected oligonucleotides complementary to the alpha-sarcin loop of 28S RNA abolish protein synthesis in Xenopus oocytes. Journal of Biological Chemistry 1990; 265: 3263-3269.
51. Shang M, Song H, Liu X and Tang Z. Detection and quantitation of PS20, a phosphorothioate oligodeoxynucleotides in monkey plasma. Acta Pharmacologica Sinica 2004; 25: 801-806.
52. Slater GW and Noolandi J, On the reptation theory of gel electrophoresis. Biopolymers 1986; 25: 431-454.
53. Song L, Liu T, Liang D, Fang D and Chu B. Separation of double-stranded DNA fragments by capillary electrophoresis in interpenetrating networks of polyacrylamide and polyvinylpyrrolidone. Electrophoresis 2001; 22: 3688-3698.
54. Soucy NV, Templin MV, Geary RS, de Peyster A and Levin A. Maternal and fetal disposition of a phosphorothioate oligonucleotide in rats following intravenous infusion. Birth Defects Research, Part B: Developmental and Reproductive Technology 2006; 77: 22-28.
55. Stepkowski SM, Qu X, Wang ME, Tian L, Chen W, Wancewicz EV, Johnston JF, Bennett CF and Monia BP. Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats. Transplantation 2000; 70: 656-661.
56. Szekely L, Kiessig S, Schwarz MA and Kalman F. Capillary electrophoresis of therapeutic oligonucleotides - analysis of single- and double-stranded forms. Electrophoresis 2009; 30: 1579-1586.
57. Tanaka T. Gels. Scientific American 1981; 244: 124-138.
58. Templin MV, Levin AA, Graham MJ, Âberg PM, Axelsson BI, Butler M, Geary RS and Bennet CF. Antisense & Nucleic Acid Drug Development 2000; 10: 359-368.
59. Wallace TL, Bazemore SA, Kornbrust DJ and Cossum PA. Single-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys. Journal of Pharmacology and Experimental Therapy 1996; 278: 1306-1312.
60. Wang Q, Xu X and Dai L. A new quasi-interpenetrating network formed by poly(N-acryloyl-tris-(hydroxymethyl)aminomethane) and polyvinylpyrrolidone: Separation matrix for double-stranded DNA and single-stranded DNA fragments by capillary electrophoresis with UV detection. Electrophoresis 2006; 27: 1749-1757.
61. Willems AV, Deforce DL, Van Peteghem CH and Van Bocxlaer JF. Analysis of nucleic acid constituents by on-line capillary electrophoresis-mass spectrometry. Electrophoresis 2005; 26(7-8): 1221-1253.
62. Wu L, Lu D, Zhou Z, Zhang H, Zhang Y and Wang S. A combined solid phase extraction/capillary gel electrophoresis method for the determination of phosphorothioate oligodeoxynucleotides in biological fluids, tissues and feces. Journal of Chromatography B 2009; 877: 361-368.
63. Yu RZ, Geary RS, Leeds JM, Watanabe T, Moore M, Fitchett J, Matson J, Burckin T, Templin MV and Levin AA. Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkey. Journal of Pharmaceutical Science 2001; 90: 182-193.
64. Yu RZ, Geary RS, Monteith DK, Matson J, Truong L, Fitchett J and Levin AA. Tissue disposition of a 2′-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys. Journal of Pharmaceutical Science 2004; 93: 48-59.
65. Zhang J, Liang D, He W, Wan F, Ying Q and Chu B. Fast separation of single-stranded oligonucleotides by capillary electrophoresis using OliGreen® as fluorescence inducing agent. Eletrophoresis 2005; 26: 4449-4455.